ObservSMART Continues Rollout of Patient Safety Technology

AltaPointe Health is the Latest Healthcare System to Utilize Innovative Compliance Solution

ObservSMART, a patient safety compliance solution, announced today that AltaPointe Health in Mobile, Alabama, has recently started using its technology to ensure patient safety while reducing risk, errors, and costs.

An easy-to-use observation tool, ObservSMART is an innovative product of InvisALERT Solutions, developed to improve patient safety and overall quality of care for high-risk patient populations.

AltaPointe Health has deployed the ObservSMART technology at BayPointe Hospital, which treats pediatric psychiatric patients, and at EastPointe Hospital, which cares for adults.

“BayPointe Hospital provides more than 100,000 hospital services to children each year, and safety is our top priority. Incorporating ObservSMART, the next generation of technology, into our daily patient observations helps us ensure patient safety while maintaining the highest quality of care,” said Jarrett Crum, Chief Hospital Officer for AltaPointe Health.

ObservSMART is a proximity-based system that syncs a patented, tamper-resistant wristband with a tablet to validate required patient observations, specifically designed for higher acuity patient populations, or patients in need of frequent monitoring. The staff member needs to be within a certain proximity to the patient to validate their patient check. The ObservSMART App also provides real-time staff reminders to check on their patients. In addition, leadership and other supervisors receive alerts for missed observations and additional safety concerns, allowing them to intervene in real-time, mitigating the potential of risk.

“In today’s health care landscape, patients expect hospitals and health systems to provide high-quality care. Keeping our programs on the cutting edge of technology allows us to meet and hopefully exceed those expectations,” said Steve Dolan, VP of Administrative Services for AltaPointe Health.

Christopher Dunn, Senior Vice President with ObservSMART, looks forward to working in partnership with AltaPointe Health, a leading provider in Alabama, to improve patient safety, staff communications, and accountability to provide the highest quality of care to its patients.

“Our technology aligns well with AltaPointe’s quality of care initiatives and the exceptional standards already in place. ObservSMART will help them in their quest to better assist those suffering from behavioral health challenges” he said.

 

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.